Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
A Systematic Review and Meta-Analysis of the Relationship Between Statin Intake and Esophageal Cancer Publisher Pubmed



Khaghani A1 ; Kasiri K2 ; Heidarisoureshjani S3 ; Sherwin CMT4 ; Mardaninafchi H5
Authors
Show Affiliations
Authors Affiliations
  1. 1. Skin Diseases and Leishmaniasis Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
  2. 2. Department of Pediatrics, Shahrekord University of Medical Sciences, Shahrekord, Iran
  3. 3. Modeling in Health Research Center, Shahrekord University of Medical Sciences, Shahrekord, Iran
  4. 4. Pediatric Clinical Pharmacology and Toxicology, Department of Pediatrics, Wright State University Boonshoft School of Medicine, Dayton Children's Hospital, One Children's Plaza, Dayton, OH, United States
  5. 5. Department of Pharmacology, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Source: Anti-Cancer Agents in Medicinal Chemistry Published:2024


Abstract

Background: Esophageal cancer is a malignant tumor with a low survival rate. Statins, commonly prescribed for their lipid-lowering effects, have been suggested to possess potential chemopreventive properties against various cancers, including esophageal cancer. Objectives: This systematic review studied the association between statin intake and esophageal cancer. Methods: To conduct this systematic review and meta-analysis, we reviewed studies published between 1980 and June 2023 in Web of Science (WOS), Embase, MEDLINE/PubMed, Scopus, and Cochrane Library databases according to the PRISMA guidelines. Data extraction, quality assessment, and statistical analyses were performed using predefined protocols. We used various statistical tests conducted by Stata statistical software. Statistical significance was considered significant at p < 0.05. Results: Twenty-one studies were collected and analyzed. The meta-analysis demonstrated that the odds ratio (OR) of esophageal cancer in patients treated with statins was 0.65 (95% CI: 0.57-0.75, p <0.001) compared to the non-receiving group. The ORs for case-control and cohort studies were 0.67 (95% CI:0.54-0.83, p < 0.001) and 0.62 (95% CI:0.55-0.71, p < 0.001), respectively. The investigation into the relationship between the statins intake and the incidence of esophageal cancer did not reveal any indication of publication bias according to both Begg's test (p = 0.966) and Egger's test (p = 0.113). Conclusion: The results revealed that the odds of esophageal cancer in patients treated with statins decreased by 35% compared to patients not treated with statins. However, further well-designed prospective studies are needed to validate these findings and understand the underlying mechanisms of statins in preventing esophageal cancer. © 2024 Bentham Science Publishers.
Experts (# of related papers)
Other Related Docs
9. Respiratory Complications After Transhiatal Esophagectomy, Journal of Isfahan Medical School (2009)
25. The Tangled Web of Dyslipidemia and Cancer: Is There Any Association?, Journal of Research in Medical Sciences (2022)
39. The Effect of Lutein and Zeaxanthine on Dyslipidemia: A Meta-Analysis Study, Prostaglandins and Other Lipid Mediators (2023)